Medtronic, The Foundry Invest In New Transcatheter Mitral Repair Technology
The deal gives Medtronic the exclusive right to acquire Half Moon Medical, a start-up developing a mitral valve repair system to compete with Abbott’s MitraClip.
You may also be interested in...
The company is sponsoring an early feasibility trial of the Intrepid transcatheter valve replacement system for patients with severe tricuspid regurgitation.
A new trial will evaluate the feasibility of implanting Medtronic's Intrepid transcatheter mitral valve replacement system through a transfemoral approach after the Intrepid TMVR study showed the feasibility of implanting Intrepid through the transapical approach.
The race to develop the best transcatheter mitral replacement valve technology continues to heat-up with Medtronic's $458m acquisition of Twelve, Inc.